Selecta Therapeutics
Immunomodulation

Selecta is a biotechnology company developing novel drugs that use immune modulating nanomedicines to generate antigen-specific immune responses to prevent and treat disease. The company is applying its SVP platform to create first-in-class antigen-specific tolerogenic immunotherapeutics that are designed to prevent undesired immune responses in auto-immune diseases, biologic therapy and allergies. NASDAQ: SELB


University
Harvard University
Sector
Life Science
Status
Public
Initial Investment Stage
Late
View Website